{
    "code": "02023265",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02023265",
    "time": "2020-05-22 04:57:13",
    "許可證字號": "衛署藥輸字第023265號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/08\/20",
    "發證日期": "90\/08\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202326504",
    "中文品名": "〝吸必擴〞都保定量粉狀吸入劑160／4.5μg／dose",
    "英文品名": "SYMBICORT TURBUHALER 160\/4.5MCG\/DOSE",
    "適應症": "１.\t氣喘（Asthma）\r\n適合使用類固醇及長效β2 作用劑（β2-agonist）合併治療的支氣管氣喘（Bronchial asthma）。\r\n２.\t慢性阻塞性肺部疾病（COPD）\r\n適用於18 歲以上患有慢性阻塞性肺部疾病（COPD），使用氣管擴張劑後之第一秒吐氣量（post-bronchodilator FEV1）少於預測值之70%及已定期使用支氣管擴張劑，而仍有惡化病史的病患之治療。",
    "劑型": "105粉狀吸入劑",
    "包裝": "160\/4.5μg\/dose，每瓶60, 120劑量定量吸入瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE",
    "限制項目": "02輸　入",
    "申請商名稱": "1434901100  臺灣阿斯特捷利康股份有限公司",
    "申請商地址": "台北市大安區敦化南路二段207號21樓",
    "主製造廠": [
        {
            "製造廠名稱": "FSE0022000  ASTRAZENECA AB",
            "製造廠廠址": "S-151 85 SODERTALJE  SWEDEN",
            "製造廠公司地址": "",
            "製造廠國別": "SWEDEN",
            "製程": ""
        }
    ],
    "CCC號列": "30043200002 其他醫藥製劑，含有腎上腺皮質類固醇荷爾蒙及其衍生物或結構式類似者Other medicaments, containing corticosteroid hormones, their derivatives or structural analogues",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216003030",
            "成分名稱": "FORMOTEROL FUMARATE DIHYDRATE",
            "含量描述": "",
            "含量": "4.5000000000",
            "單位": "MCG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "8406002100",
            "成分名稱": "BUDESONIDE",
            "含量描述": "",
            "含量": "160.0000000000",
            "單位": "MCG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Symbicort Turbuhaler 160 4.5-In-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023265&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "20200210-Symbicort Turbuhaler 160 4.5-核定中文仿單-clean-109-03-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023265&Seq=031&Type=9"
        },
        {
            "title": "Symbicort Turbuhaler 吸必擴都保 160 4.5 中文仿單 2018-108-04-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023265&Seq=030&Type=9"
        },
        {
            "title": "020232650002.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02023265&Seq=002&Type=8"
        }
    ]
}